comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 20:16:07 - browse：51

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： FogPharma raises $145 million in rare Series E round

focus

WSS

STAT Summit: Ending the crisis of Black deaths in the U.S.

FDA clears Verve to begin U.S. study of gene

RSV vaccines may be linked to small increased risk of developing GBS

International team creates first chimeric human

STAT Readout: Friday, Oct. 20 biotech updates

Health tech investors get more selective as pandemic boom fades

Wikipedia

comprehensive

focus

Medical leaders decry Supreme Court decision on affirmative action

How AI can help patients find reliable information about doctors

Anesthesiologist group: stop taking Ozempic before surgery

Medical device lobby: We're tired of waiting on Medicare coverage

Medical leaders decry Supreme Court decision on affirmative action

CZI to create biohub to build anti

Psychedelics group wrestles with new pharma identity

Questions loom on AstraZeneca cancer drug as safety concerns ebb

United colonoscopy coverage change 'may cost lives,' doctors say

RaDonda Vaught to speak at CommonSpirit event on patient safety

knowledge

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Congress gives doctors Medicare pay bump

Congress gives doctors Medicare pay bump

Medical device lobby: We're tired of waiting on Medicare coverage

STAT Summit: The economic case for universal basic health care

Is there really a nursing shortage in the U.S.?

leisure time

focus

focus

hotspot